Effects of roxithromycin on neutrophil chemotaxis and phagocytosis in vitro.
Hirohiko Akamatsu, Hiroko Sasaki, Yoko Matoba, Shuhei Ri, Setsuko Nishijima, Yasuo Asada
Abstract
Open-access reader
Hirohiko Akamatsu, Hiroko Sasaki, Yoko Matoba, Shuhei Ri, Setsuko Nishijima, Yasuo Asada
Abstract
Open-access reader
The effects of roxithromycin, a new orally semisynthetic macrolide, were investigated on human neutrophil chemotaxis and phagocytosis in vitro. The agent markedly stimulated neutrophil chemotaxis and phagocytosis in a dose-dependent manner. These results may indicate that roxith-romycin potentiates the activation of neutrophils in vivo.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effects of roxithromycin, a new orally semisynthetic macrolide, were investigated on human neutrophil chemotaxis and phagocytosis in vitro. The agent markedly stimulated neutrophil chemotaxis and phagocytosis in a dose-dependent manner. These results may indicate that roxith-romycin potentiates the activation of neutrophils in vivo.
Key concepts: Roxithromycin, Phagocytosis, Chemotaxis, In vitro, In vivo, Chemistry, Microbiology, Immunology